Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

L'Oreal FY11 Profit Rises - Quick Facts

L'Oreal SA (LRLCY.PK) Monday reported an increase in profit for the full-year 2011, as sales and gross margins improved.

Net profit excluding non-recurring items after non-controlling interests for the full-year 2011 improved to 2.58 billion euros or 4.32 euro per share from 2.37 billion euros or 4.01 euro per share last year.

Net profit after non-controlling interests for the period was 2.44 billion euros or 4.08 euro per share compared to 2.24 billion euros or 3.79 euro per share last year.

Sales for the full-year rose to 20.34 billion euros from 19.50 billion euros last year. On a like-for-like basis, sales for the year increased 5.1 percent from last year.

Full-year gross margin advanced 40 basis points to 71.2 percent.

Click here to receive FREE breaking news email alerts for L'Oreal Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.